Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody–Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Ne... by Yan Wang, Hangcheng Xu, Yiqun Han, Yun Wu, Jiayu Wang

Get full text

Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-Analysis by Yiqun Han, Jiayu Wang, Yun Wu, Hangcheng Xu, Yan Wang, Binghe Xu

Get full text

CDK4/6 inhibitors versus PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated systematic review and network meta-ana... by Hangcheng Xu, Yan Wang, Yiqun Han, Yun Wu, Jiayu Wang, Binghe Xu

Get full text

Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population‐based analysis by Hangcheng Xu, Yiqun Han, Yun Wu, Yan Wang, Jiayu Wang, Binghe Xu

Get full text

New insights into HER2-low breast cancer brain metastasis: A retrospective analysis by Hangcheng Xu, Yan Wang, Li Li, Yiqun Han, Yun Wu, Qiang Sa, Binghe Xu, Jiayu Wang

Get full text

Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience by Hangcheng Xu, Yiqun Han, Yun Wu, Yan Wang, Qing Li, Pin Zhang, Peng Yuan, Yang Luo, Ying Fan, Shanshan Chen, Ruigang Cai, Qiao Li, Fei Ma, Binghe Xu, Jiayu Wang

Get full text

Docetaxel plus S-1 versus docetaxel plus capecitabine as first-line treatment for advanced breast cancer patients: a prospective randomized phase II study by Nilupai Abudureheiyimu, Yun Wu, Qing Li, Pin Zhang, Fei Ma, Peng Yuan, Yang Luo, Ying Fan, Shanshan Chen, Ruigang Cai, Qiao Li, Yiqun Han, Hangcheng Xu, Yan Wang, Jiayu Wang, Binghe Xu

Get full text